Literature DB >> 6309797

Fibrinogen binding to human platelet plasma membranes. Identification of two steps requiring divalent cations.

D R Phillips, A K Baughan.   

Abstract

Fibrinogen binding to platelet plasma membranes, which is a prerequisite for platelet aggregation, was determined by incubating 125I-labeled fibrinogen with isolated membranes and measuring the amount of radioactivity sedimenting with the membranes through 15% sucrose. Fibrinogen binding was optimal at 10(-3) M Ca2+. Scatchard analyses of the fibrinogen binding showed that the membrane capacity for fibrinogen was 1.6 X 10(-12) mol/mg of membrane protein, with a dissociation constant (Kd) = 1.2 X 10(-8) M. When Ca2+ levels were manipulated by the addition of varying amounts of EGTA at a fixed Mg2+ concentration of 3 X 10(-3) M, specific binding of fibrinogen to platelet membranes occurred only at Ca2+ concentrations greater than or equal to 10(-6) M. Membranes isolated from platelets of an individual with Glanzmann's thrombasthenia bound only 12% as much fibrinogen as control platelets. The data in the present study suggest that there are two divalent cation binding sites that must be occupied for fibrinogen to bind: one site is specific for calcium and is saturated at 10(-6) M Ca2+; the other site is less specific and is saturated at a 10(-3) M concentration of either Ca2+ or Mg2+. Fibrinogen binding to intact platelets and, consequently, platelet aggregation only required 10(-3) M extracellular divalent cation and was not specific for Ca2+. These data indicate that the cytoplasm is a potential source for the requirement of 10(-6) M Ca2+, and that changes in the intracellular concentration of Ca2+ may cause the expression of fibrinogen receptors during ADP-induced platelet activation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309797

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  The human platelet fibrinogen receptor: clinical and therapeutic significance.

Authors:  M Cahill; R Mistry; D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

2.  Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets.

Authors:  G van Willigen; J W Akkerman
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

3.  Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia.

Authors:  M H Ginsberg; A Lightsey; T J Kunicki; A Kaufmann; G Marguerie; E F Plow
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

4.  Regulation of ligand binding to glycoprotein IIb-IIIa (integrin alpha IIb beta 3) in isolated platelet membranes.

Authors:  S S Smyth; L V Parise
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

Review 5.  Reconstruction of integrin activation.

Authors:  Feng Ye; Chungho Kim; Mark H Ginsberg
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

6.  Ligands to the platelet fibrinogen receptor glycoprotein IIb-IIIa do not affect agonist-induced second messengers Ca2+ or cyclic AMP.

Authors:  J A Williams; B Ashby; J L Daniel
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

7.  Reconstruction of platelet proteins into phospholipid vesicles. Functional proteoliposomes.

Authors:  J J Baldassare; R A Kahn; M A Knipp; P J Newman
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

8.  Lipids of the platelet membrane.

Authors:  E L Bearer; D S Friend
Journal:  Lab Invest       Date:  1986-02       Impact factor: 5.662

9.  The role of cytoplasmic free calcium in the responses of quin2-loaded human platelets to vasopressin.

Authors:  T J Hallam; N T Thompson; M C Scrutton; T J Rink
Journal:  Biochem J       Date:  1984-08-01       Impact factor: 3.857

10.  Capture by chemical crosslinkers provides evidence that integrin alpha IIb beta 3 forms a complex with protein tyrosine kinases in intact platelets.

Authors:  D J Dorahy; M C Berndt; G F Burns
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.